網膜血管閉塞の世界市場：市場規模・現状・予測

• 英文タイトル：Global Retinal Vascular Occlusion Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST05022
• 出版社/出版日：QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

※当調査レポートでは、網膜血管閉塞の世界市場について調査・分析し、網膜血管閉塞の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗血管内皮増殖因子（VEGF）、コルチコステロイド、抗凝固剤、線溶剤、その他）、用途別（病院及びクリニック、研究及び学術、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。

・レポートの概要
・世界の網膜血管閉塞市場動向
・主要企業別マーケットシェア
・網膜血管閉塞の種類別市場規模2014-2019
（抗血管内皮増殖因子（VEGF）、コルチコステロイド、抗凝固剤、線溶剤、その他）
・網膜血管閉塞の用途別市場規模2014-2019
（病院及びクリニック、研究及び学術、その他）
・網膜血管閉塞の北米市場：主要企業・種類別/用途別市場規模
・網膜血管閉塞のヨーロッパ市場：主要企業・種類別/用途別市場規模
・網膜血管閉塞の中国市場：主要企業・種類別/用途別市場規模
・網膜血管閉塞の日本国内市場：主要企業・種類別/用途別市場規模
・網膜血管閉塞の東南アジア市場：主要企業・種類別/用途別市場規模
・網膜血管閉塞のインド市場：主要企業・種類別/用途別市場規模
・網膜血管閉塞の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Regeneron Pharmaceuticals, Inc.、Bayer HealthCare Pharmaceuticals LLC.、Novartis AG、Pfizer, Inc.、AstraZeneca PLC.、GlaxoSmithKline PLC.、Johnson & Johnson、Teva pharmaceutical industries、Novo Nordisk、Sanofi）
・網膜血管閉塞の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...

Retinal Vascular Occlusion (RVO) is the build-up of blood or other fluids in the retina of the eye, which prevents it from properly filtering light caused by the blood clot.The Americas account for a significant market share owing to high expenditure on the health care, especially, of the U.S. and Canada. Additionally, the greater number of ophthalmology procedures due to greater healthcare penetration in the U.S. and Canada drives the retinal vascular occlusion market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of ophthalmology procedures, especially, the retinal vascular occlusion surgery treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retinal vascular occlusion market in the US. The high development of the microsurgery field in developed regions such as the U.S. and Europe is a strong driver of the market.
In 2018, the global Retinal Vascular Occlusion market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Retinal Vascular Occlusion status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Vascular Occlusion development in United States, Europe and China.

The key players covered in this study
Regeneron Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals LLC.
Novartis AG
Pfizer, Inc.
AstraZeneca PLC.
GlaxoSmithKline PLC.
Johnson & Johnson
Teva pharmaceutical industries
Novo Nordisk
Sanofi

Market segment by Type, the product can be split into
Anti-vascular Endothelial Growth Factor (VEGF)
Corticosteroid
Anticoagulants
Fibrinolytic
Others

Market segment by Application, split into
Hospitals and Clinics
Research and Academics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Retinal Vascular Occlusion status, future forecast, growth opportunity, key market and key players.
To present the Retinal Vascular Occlusion development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Retinal Vascular Occlusion are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Retinal Vascular Occlusion Market Size Growth Rate by Type (2014-2025)
1.4.2 Anti-vascular Endothelial Growth Factor (VEGF)
1.4.3 Corticosteroid
1.4.4 Anticoagulants
1.4.5 Fibrinolytic
1.4.6 Others
1.5 Market by Application
1.5.1 Global Retinal Vascular Occlusion Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Research and Academics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Retinal Vascular Occlusion Market Size
2.2 Retinal Vascular Occlusion Growth Trends by Regions
2.2.1 Retinal Vascular Occlusion Market Size by Regions (2014-2025)
2.2.2 Retinal Vascular Occlusion Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Retinal Vascular Occlusion Market Size by Manufacturers
3.1.1 Global Retinal Vascular Occlusion Revenue by Manufacturers (2014-2019)
3.1.2 Global Retinal Vascular Occlusion Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Retinal Vascular Occlusion Market Concentration Ratio (CR5 and HHI)
3.2 Retinal Vascular Occlusion Key Players Head office and Area Served
3.3 Key Players Retinal Vascular Occlusion Product/Solution/Service
3.4 Date of Enter into Retinal Vascular Occlusion Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Retinal Vascular Occlusion Market Size by Type (2014-2019)
4.2 Global Retinal Vascular Occlusion Market Size by Application (2014-2019)

5 United States
5.1 United States Retinal Vascular Occlusion Market Size (2014-2019)
5.2 Retinal Vascular Occlusion Key Players in United States
5.3 United States Retinal Vascular Occlusion Market Size by Type
5.4 United States Retinal Vascular Occlusion Market Size by Application

6 Europe
6.1 Europe Retinal Vascular Occlusion Market Size (2014-2019)
6.2 Retinal Vascular Occlusion Key Players in Europe
6.3 Europe Retinal Vascular Occlusion Market Size by Type
6.4 Europe Retinal Vascular Occlusion Market Size by Application

7 China
7.1 China Retinal Vascular Occlusion Market Size (2014-2019)
7.2 Retinal Vascular Occlusion Key Players in China
7.3 China Retinal Vascular Occlusion Market Size by Type
7.4 China Retinal Vascular Occlusion Market Size by Application

8 Japan
8.1 Japan Retinal Vascular Occlusion Market Size (2014-2019)
8.2 Retinal Vascular Occlusion Key Players in Japan
8.3 Japan Retinal Vascular Occlusion Market Size by Type
8.4 Japan Retinal Vascular Occlusion Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Retinal Vascular Occlusion Market Size (2014-2019)
9.2 Retinal Vascular Occlusion Key Players in Southeast Asia
9.3 Southeast Asia Retinal Vascular Occlusion Market Size by Type
9.4 Southeast Asia Retinal Vascular Occlusion Market Size by Application

10 India
10.1 India Retinal Vascular Occlusion Market Size (2014-2019)
10.2 Retinal Vascular Occlusion Key Players in India
10.3 India Retinal Vascular Occlusion Market Size by Type
10.4 India Retinal Vascular Occlusion Market Size by Application

11 Central & South America
11.1 Central & South America Retinal Vascular Occlusion Market Size (2014-2019)
11.2 Retinal Vascular Occlusion Key Players in Central & South America
11.3 Central & South America Retinal Vascular Occlusion Market Size by Type
11.4 Central & South America Retinal Vascular Occlusion Market Size by Application

12 International Players Profiles
12.1 Regeneron Pharmaceuticals, Inc.
12.1.1 Regeneron Pharmaceuticals, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Retinal Vascular Occlusion Introduction
12.1.4 Regeneron Pharmaceuticals, Inc. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.1.5 Regeneron Pharmaceuticals, Inc. Recent Development
12.2 Bayer HealthCare Pharmaceuticals LLC.
12.2.1 Bayer HealthCare Pharmaceuticals LLC. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Retinal Vascular Occlusion Introduction
12.2.4 Bayer HealthCare Pharmaceuticals LLC. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.2.5 Bayer HealthCare Pharmaceuticals LLC. Recent Development
12.3 Novartis AG
12.3.1 Novartis AG Company Details
12.3.2 Company Description and Business Overview
12.3.3 Retinal Vascular Occlusion Introduction
12.3.4 Novartis AG Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.3.5 Novartis AG Recent Development
12.4 Pfizer, Inc.
12.4.1 Pfizer, Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Retinal Vascular Occlusion Introduction
12.4.4 Pfizer, Inc. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.4.5 Pfizer, Inc. Recent Development
12.5 AstraZeneca PLC.
12.5.1 AstraZeneca PLC. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Retinal Vascular Occlusion Introduction
12.5.4 AstraZeneca PLC. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.5.5 AstraZeneca PLC. Recent Development
12.6 GlaxoSmithKline PLC.
12.6.1 GlaxoSmithKline PLC. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Retinal Vascular Occlusion Introduction
12.6.4 GlaxoSmithKline PLC. Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.6.5 GlaxoSmithKline PLC. Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Retinal Vascular Occlusion Introduction
12.7.4 Johnson & Johnson Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.7.5 Johnson & Johnson Recent Development
12.8 Teva pharmaceutical industries
12.8.1 Teva pharmaceutical industries Company Details
12.8.2 Company Description and Business Overview
12.8.3 Retinal Vascular Occlusion Introduction
12.8.4 Teva pharmaceutical industries Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.8.5 Teva pharmaceutical industries Recent Development
12.9 Novo Nordisk
12.9.1 Novo Nordisk Company Details
12.9.2 Company Description and Business Overview
12.9.3 Retinal Vascular Occlusion Introduction
12.9.4 Novo Nordisk Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.9.5 Novo Nordisk Recent Development
12.10 Sanofi
12.10.1 Sanofi Company Details
12.10.2 Company Description and Business Overview
12.10.3 Retinal Vascular Occlusion Introduction
12.10.4 Sanofi Revenue in Retinal Vascular Occlusion Business (2014-2019)
12.10.5 Sanofi Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Retinal Vascular Occlusion Key Market Segments
Table Key Players Retinal Vascular Occlusion Covered
Table Global Retinal Vascular Occlusion Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Retinal Vascular Occlusion Market Size Market Share by Type 2014-2025
Figure Anti-vascular Endothelial Growth Factor (VEGF) Figures
Table Key Players of Anti-vascular Endothelial Growth Factor (VEGF)
Figure Corticosteroid Figures
Table Key Players of Corticosteroid
Figure Anticoagulants Figures
Table Key Players of Anticoagulants
Figure Fibrinolytic Figures
Table Key Players of Fibrinolytic
Figure Others Figures
Table Key Players of Others
Table Global Retinal Vascular Occlusion Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Research and Academics Case Studies
Figure Others Case Studies
Figure Retinal Vascular Occlusion Report Years Considered
Table Global Retinal Vascular Occlusion Market Size 2014-2025 (Million US$)
Figure Global Retinal Vascular Occlusion Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Retinal Vascular Occlusion Market Size by Regions 2014-2025 (Million US$)
Table Global Retinal Vascular Occlusion Market Size by Regions 2014-2019 (Million US$)
Table Global Retinal Vascular Occlusion Market Share by Regions 2014-2019
Figure Global Retinal Vascular Occlusion Market Share by Regions 2014-2019
Figure Global Retinal Vascular Occlusion Market Share by Regions 2019
Table Market Top Trends
Table Global Retinal Vascular Occlusion Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Retinal Vascular Occlusion Market Share by Manufacturers (2014-2019)
Figure Global Retinal Vascular Occlusion Market Share by Manufacturers in 2018
Table Global Retinal Vascular Occlusion Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Retinal Vascular Occlusion Product/Solution/Service
Table Date of Enter into Retinal Vascular Occlusion Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Retinal Vascular Occlusion Market Size by Type (2014-2019) (Million US$)
Table Global Retinal Vascular Occlusion Market Size Share by Type (2014-2019)
Figure Global Retinal Vascular Occlusion Market Size Market Share by Type (2014-2019)
Table Global Retinal Vascular Occlusion Market Size by Application (2014-2019) (Million US$)
Table Global Retinal Vascular Occlusion Market Size Share by Application (2014-2019)
Figure Global Retinal Vascular Occlusion Market Size Market Share by Application (2014-2019)
Figure Global Retinal Vascular Occlusion Revenue Market Share by Application in 2018
Figure United States Retinal Vascular Occlusion Market Size 2014-2019 (Million US$)
Table United States Key Players Retinal Vascular Occlusion Revenue (2018-2019) (Million US$)
Table United States Key Players Retinal Vascular Occlusion Market Share (2018-2019)
Table United States Retinal Vascular Occlusion Market Size by Type (2014-2019) (Million US$)
Table United States Retinal Vascular Occlusion Market Share by Type (2014-2019)
Table United States Retinal Vascular Occlusion Market Size by Application (2014-2019) (Million US$)
Table United States Retinal Vascular Occlusion Market Share by Application (2014-2019)
Figure Europe Retinal Vascular Occlusion Market Size 2014-2019 (Million US$)
Table Europe Key Players Retinal Vascular Occlusion Revenue (2018-2019) (Million US$)
Table Europe Key Players Retinal Vascular Occlusion Market Share (2018-2019)
Table Europe Retinal Vascular Occlusion Market Size by Type (2014-2019) (Million US$)
Table Europe Retinal Vascular Occlusion Market Share by Type (2014-2019)
Table Europe Retinal Vascular Occlusion Market Size by Application (2014-2019) (Million US$)
Table Europe Retinal Vascular Occlusion Market Share by Application (2014-2019)
Figure China Retinal Vascular Occlusion Market Size 2014-2019 (Million US$)
Table China Key Players Retinal Vascular Occlusion Revenue (2018-2019) (Million US$)
Table China Key Players Retinal Vascular Occlusion Market Share (2018-2019)
Table China Retinal Vascular Occlusion Market Size by Type (2014-20189) (Million US$)
Table China Retinal Vascular Occlusion Market Share by Type (2014-2019)
Table China Retinal Vascular Occlusion Market Size by Application (2014-2019) (Million US$)
Table China Retinal Vascular Occlusion Market Share by Application (2014-2019)
Figure Japan Retinal Vascular Occlusion Market Size 2014-2019 (Million US$)
Table Japan Key Players Retinal Vascular Occlusion Revenue (2018-2019) (Million US$)
Table Japan Key Players Retinal Vascular Occlusion Market Share (2018-2019)
Table Japan Retinal Vascular Occlusion Market Size by Type (2014-2019) (Million US$)
Table Japan Retinal Vascular Occlusion Market Share by Type (2014-2019)
Table Japan Retinal Vascular Occlusion Market Size by Application (2014-2019) (Million US$)
Table Japan Retinal Vascular Occlusion Market Share by Application (2014-2019)
Figure Southeast Asia Retinal Vascular Occlusion Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Retinal Vascular Occlusion Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Retinal Vascular Occlusion Market Share (2018-2019)
Table Southeast Asia Retinal Vascular Occlusion Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Retinal Vascular Occlusion Market Share by Type (2014-2019)
Table Southeast Asia Retinal Vascular Occlusion Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Retinal Vascular Occlusion Market Share by Application (2014-2019)
Figure India Retinal Vascular Occlusion Market Size 2014-2019 (Million US$)
Table India Key Players Retinal Vascular Occlusion Revenue (2018-2019) (Million US$)
Table India Key Players Retinal Vascular Occlusion Market Share (2018-2019)
Table India Retinal Vascular Occlusion Market Size by Type (2014-2019) (Million US$)
Table India Retinal Vascular Occlusion Market Share by Type (2014-2019)
Table India Retinal Vascular Occlusion Market Size by Application (2014-2019) (Million US$)
Table India Retinal Vascular Occlusion Market Share by Application (2014-2019)
Figure Central & South America Retinal Vascular Occlusion Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Retinal Vascular Occlusion Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Retinal Vascular Occlusion Market Share (2018-2019)
Table Central & South America Retinal Vascular Occlusion Market Size by Type (2014-2019) (Million US$)
Table Central & South America Retinal Vascular Occlusion Market Share by Type (2014-2019)
Table Central & South America Retinal Vascular Occlusion Market Size by Application (2014-2019) (Million US$)
Table Central & South America Retinal Vascular Occlusion Market Share by Application (2014-2019)
Table Regeneron Pharmaceuticals, Inc. Company Details
Table Regeneron Pharmaceuticals, Inc. Revenue in Retinal Vascular Occlusion Business (2014-2019) (Million US$)
Figure Regeneron Pharmaceuticals, Inc. Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table Regeneron Pharmaceuticals, Inc. Recent Development
Table Bayer HealthCare Pharmaceuticals LLC. Company Details
Table Bayer HealthCare Pharmaceuticals LLC. Revenue in Retinal Vascular Occlusion Business (2014-2019)(Million US$)
Figure Bayer HealthCare Pharmaceuticals LLC. Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table Bayer HealthCare Pharmaceuticals LLC. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Retinal Vascular Occlusion Business (2014-2019)(Million US$)
Figure Novartis AG Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table Novartis AG Recent Development
Table Pfizer, Inc. Company Details
Table Pfizer, Inc. Revenue in Retinal Vascular Occlusion Business (2014-2019)(Million US$)
Figure Pfizer, Inc. Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table Pfizer, Inc. Recent Development
Table AstraZeneca PLC. Company Details
Table AstraZeneca PLC. Revenue in Retinal Vascular Occlusion Business (2014-2019)(Million US$)
Figure AstraZeneca PLC. Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table AstraZeneca PLC. Recent Development
Table GlaxoSmithKline PLC. Company Details
Table GlaxoSmithKline PLC. Revenue in Retinal Vascular Occlusion Business (2014-2019)(Million US$)
Figure GlaxoSmithKline PLC. Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table GlaxoSmithKline PLC. Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Retinal Vascular Occlusion Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Teva pharmaceutical industries Company Details
Table Teva pharmaceutical industries Revenue in Retinal Vascular Occlusion Business (2014-2019)(Million US$)
Figure Teva pharmaceutical industries Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table Teva pharmaceutical industries Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Retinal Vascular Occlusion Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table Novo Nordisk Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Retinal Vascular Occlusion Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Retinal Vascular Occlusion Business (2014-2019)
Table Sanofi Recent Development
Table Global Retinal Vascular Occlusion Market Size by Regions (Million US$) 2019-2025
Figure Global Retinal Vascular Occlusion Market Size Share by Regions (2019-2025)
Figure Global Retinal Vascular Occlusion Market Size Share by Regions in 2025
Figure United States Retinal Vascular Occlusion Market Size Forecast (2019-2025)(Million USD)
Figure Europe Retinal Vascular Occlusion Market Size Forecast (2019-2025)(Million USD)
Figure China Retinal Vascular Occlusion Market Size Forecast (2019-2025)(Million USD)
Figure Japan Retinal Vascular Occlusion Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Retinal Vascular Occlusion Market Size Forecast (2019-2025)(Million USD)
Figure India Retinal Vascular Occlusion Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Retinal Vascular Occlusion Market Size Forecast (2019-2025)(Million USD)
Table Global Retinal Vascular Occlusion Market Size by Product (2019-2025) (Million US$)
Figure Global Retinal Vascular Occlusion Market Size by Product (2019-2025)
Figure Global Retinal Vascular Occlusion Market Size by Product in 2025
Table Global Retinal Vascular Occlusion Market Size by Application (2019-2025) (Million US$)
Figure Global Retinal Vascular Occlusion Market Size by Application (2019-2025)
Figure Global Retinal Vascular Occlusion Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

網膜血管閉塞の世界市場：市場規模・現状・予測

Global Retinal Vascular Occlusion Market Size, Status and Forecast 2019-2025
QYR9ST05022 2019年9月2日 99Pages
※当調査レポートでは、網膜血管閉塞の世界市場について調査・分析し、網膜血管閉塞の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗血管内皮増殖因子（VEGF）、コルチコステロイド、抗凝固剤、線溶剤、そ...

網膜静脈閉塞症治療の世界市場：市場規模・現状・予測

Global Retinal Vein Occlusion Therapeutics Market Size, Status and Forecast 2019-2025
QYR9ST05023 2019年9月2日 95Pages
※当調査レポートでは、網膜静脈閉塞症治療の世界市場について調査・分析し、網膜静脈閉塞症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（分岐網膜静脈閉塞、中央網膜静脈閉塞）、用途別（病院、外来手術...

網膜静脈閉塞症治療の世界市場：市場規模・現状・予測

人工網膜インプラントの世界市場：市場規模・現状・予測

Global Artificial Retinal Implants Market Size, Status and Forecast 2019-2025
QYR9ST03820 2019年9月2日 98Pages
※当調査レポートでは、人工網膜インプラントの世界市場について調査・分析し、人工網膜インプラントの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（網膜上インプラント、網膜下インプラント）、用途別（眼科病...

世界の網膜イメージング装置市場：専門的調査

Global Retinal Imaging Devices Market Professional Survey Report 2019
QYR9ST06276 2019年9月2日 101Pages
※本調査レポートは、網膜イメージング装置の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、OCT、眼底カメラに、用途別には、病院、眼科、その他にセグメント区分し...

網膜薬物及び生物製剤の世界市場：インサイト・予測

Global Retinal Drugs and Biologics Market Insights, Forecast to 2025
QYR9ST01714 2019年9月2日 112Pages
※本調査レポートでは、世界の網膜薬物及び生物製剤市場について調査・分析し、以下の構成でお届け致します。網膜薬物及び生物製剤の種類別には、加齢黄斑変性、糖尿病性網膜症、眼炎症性疾患（ブドウ膜炎）、黄斑円孔に、用途別には、病院、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、...

世界の網膜硝子体プレフィルドシリコンオイルシリンジ市場：動向・競争分析

Global Vitreo Retinal Prefilled Silicone Oil Syringe Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9ST05218 2019年9月2日 118Pages
※本調査レポートでは、世界の網膜硝子体プレフィルドシリコンオイルシリンジ市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。網膜硝子体プレフィルドシリコンオイルシリンジの種類別には、1000 cst、2000 cst...

世界の網膜硝子体プレフィルドシリコンオイルシリンジ市場：動向・競争分析

世界のハンドヘルド網膜スキャナー市場：動向・競争分析

Global Handheld Retinal Scanners Industry Research Report, Growth Trends and Competitive Analysis 2019-2025
QYR9ST09521 2019年9月5日 111Pages
※本調査レポートでは、世界のハンドヘルド網膜スキャナー市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ハンドヘルド網膜スキャナーの種類別には、無散瞳、散瞳に、用途別には、医療診断、銀行及び金融、防衛及びセキュリテ...

世界の成形及び閉塞バルーン市場：専門的調査

Global Molding and Occlusion Balloon Market Professional Survey Report 2019
QYR9ST12308 2019年9月10日 116Pages
※本調査レポートは、成形及び閉塞バルーンの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ノーマルバルーンカテーテル、カッティングバルーンカテーテル、スコアリン...

網膜血管閉塞の世界市場：市場規模・現状・予測 Retinal Vascular Occlusion (RVO) is the build-up of blood or other fluids in the retina of the eye, which prevents it from properly filtering light caused by the blood clot.The Americas account for a significant market share owing to high expenditure on the health care, especially, of the U.S. and C…
網膜静脈閉塞症治療の世界市場：市場規模・現状・予測 Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization.The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRV…
網膜静脈閉塞症治療の世界市場：市場規模・現状・予測 Retinal vein occlusion (RVO) is a sight-threatening retinal vascular disorder associated with macular edema and neovascularization.The RVO is mainly of two types based on the anatomy of the vein occlusion. The two types are branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRV…
血管アクセス装置の世界市場：インサイト・予測 Vascular access refers to a rapid, direct method of introducing or removing devices or chemicals from the bloodstream. In hemodialysis, vascular access is used to remove the patient's blood so that it can be filtered through the dialyzer. The global Vascular Access Device market is valued at xx mill…
自己拡張型末梢血管ステントの世界市場：インサイト・予測 A stent is a metal or plastic tube inserted into the lumen of an anatomic vessel or duct to keep the passageway open and stenting is the placement of a stent.The high prevalence of peripheral vascular disease is expected to be drive self-expanding peripheral vascular stents market. The global Self-E…